The Molecular Medicine Ireland research portfolio can be summarised as investigations undertaken by research teams across our constitutent partner institutions into four principal disease areas supported by enabling resources and technologies as illustrated in the diagram below.

 MMI's Research Programme focuses on three key areas:

• A structured standardised framework for biobanking in Ireland
• The promotion of Technology Platforms that support translational and clinical research in molecular medicine.
• Facilitate the establishment and support of Clinical and Disease Networks

 

---

 

Research Institutes

In recent years new research laboratories have been established around Ireland within modern multi-disciplinary research institutes. These complement and work closely with the hospital-based clinical research facilities providing analytical and technological support for clinical programmes. The main research institutes are:

• UCD Conway Institute of Biomolecular & Biomedical Research at University College Dublin
• Institute of Molecular Medicine at St James' Hospital/Trinity College Dublin
• RCSI Research Institute at the Royal College of Surgeons in Ireland
• The National Centre for Biomedical Engineering Science at NUI Galway
• The BioSciences Institute at University College Cork

Technologies & Bioresources

A portfolio of new technologies and bioresources is being assembled within these institutes and within the principal teaching hospitals to support current research programmes.
Technology cores have been established in:-

• Transcriptomics
• Proteomics
• Cell Imaging
• Transgenics
• Bioinformatics

These core facilities have been centralised to ensure that they are appropriately resourced with dedicated and experienced technologists. The facilities are accessible to all investigators regardless of institutional affiliation.